Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1

Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1

Taispeáin leaganacha eile (1)

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Carlisle, R, Di, Y, Cerny, A, Sonnen, A, Sim, R, Green, N, Subr, V, Ulbrich, K, Gilbert, R, Fisher, K, Finberg, R, Seymour, L
Formáid:	Journal article
Foilsithe / Cruthaithe:	2009

Míreanna comhchosúla

Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1.
de réir: Carlisle, R, et al.
Foilsithe / Cruthaithe: (2009)

Adenovirus type 5 (Ad5) is sequestered and inactivated by binding to coxsackievirus and adenovirus receptor (CAR) and complement receptor 1 (CR1) on human erythrocytes
de réir: Carlisle, R, et al.
Foilsithe / Cruthaithe: (2008)

Coxsackie and adenovirus receptor as a limiting factor for adenovirus internalisation /
de réir: Nor Eman Ismail, 1987-, et al.
Foilsithe / Cruthaithe: (2011)

Coxsackie and adenovirus receptor as a limiting factor for adenovirus internalisation [electronic resource] /
de réir: Nor Eman Ismail, 1987-
Foilsithe / Cruthaithe: (2011)

Virotherapy of ovarian cancer with polymer-cloaked adenovirus retargeted to the epidermal growth factor receptor.
de réir: Morrison, J, et al.
Foilsithe / Cruthaithe: (2008)

Efficient adenovirus-mediated gene transfer into primary T cells and thymocytes in a new coxsackie/adenovirus receptor transgenic model
de réir: Matthews R James, et al.
Foilsithe / Cruthaithe: (2002-05-01)

Isoform-specific regulation and localization of the coxsackie and adenovirus receptor in human airway epithelia.
de réir: Katherine J D A Excoffon, et al.
Foilsithe / Cruthaithe: (2010-03-01)

Human adenovirus 52 uses sialic acid-containing glycoproteins and the coxsackie and adenovirus receptor for binding to target cells.
de réir: Annasara Lenman, et al.
Foilsithe / Cruthaithe: (2015-02-01)

Optimally stealthed Adenovirus serotype 5 shows enhanced activity and resistance to neutralisation
de réir: Thoma, C, et al.
Foilsithe / Cruthaithe: (2011)

Coating of adenovirus type 5 with polymers containing quaternary amines prevents binding to blood components.
de réir: Subr, V, et al.
Foilsithe / Cruthaithe: (2009)

Rabbit polyclonal antibody induction against human Coxsackie Adenovirus Receptor (CAR) /
de réir: 493202 Asita Elengoe, et al.
Foilsithe / Cruthaithe: (2009)

Expression of the Coxsackie and Adenovirus Receptor (CAR) in pancreatic cancer and normal pancreatic tissue
de réir: Verbeke, C. S., et al.
Foilsithe / Cruthaithe: (2006)

Essential role of the coxsackie- and adenovirus receptor (CAR) in development of the lymphatic system in mice.
de réir: Momina Mirza, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Persistent Rhesus Enteric Calicivirus Infection in Recombinant CHO Cells Expressing the Coxsackie and Adenovirus Receptor
de réir: Tibor Farkas, et al.
Foilsithe / Cruthaithe: (2024-11-01)

Passive tumour targeting of polymer-coated adenovirus for cancer gene therapy.
de réir: Fisher, K, et al.
Foilsithe / Cruthaithe: (2007)

ZEB1 limits adenoviral infectability by transcriptionally repressing the Coxsackie virus and Adenovirus Receptor
de réir: Lacher Markus D, et al.
Foilsithe / Cruthaithe: (2011-07-01)

Engineered cho cell line with coxsackie and adenovirus gene enhance the susceptibility of adenovirus infection /
de réir: Sayang Baba, 1987-, et al.
Foilsithe / Cruthaithe: (2013)

Engineered CHO cell line with coxsackie and adenovirus gene enhance the susceptibility of adenovirus infection /
de réir: Sayang Baba, 1987-, et al.
Foilsithe / Cruthaithe: (2013)

Electroporation optimisation of full-length of coxsackie and adenovirus receptor (CAR) tagged with EGFP into CHO cells /
de réir: Hamidreza Aboulkheyr Estarabadi, 1980- author, et al.
Foilsithe / Cruthaithe: (2013)

Rabbit polyclonal antibody induction against human Coxsackie Adenovirus Receptor (CAR) [electronic resource] /
de réir: 493202 Asita Elengoe, et al.
Foilsithe / Cruthaithe: (2009)

Isoform-specific expression of the Coxsackie and adenovirus receptor (CAR) in neuromuscular junction and cardiac intercalated discs
de réir: Karpati George, et al.
Foilsithe / Cruthaithe: (2004-11-01)

Retargeting polymer-coated adenovirus to the FGF receptor allows productive infection and mediates efficacy in a peritoneal model of human ovarian cancer.
de réir: Green, N, et al.
Foilsithe / Cruthaithe: (2008)

Use of synthetic vectors for neutralising antibody resistant delivery of replicating adenovirus DNA.
de réir: Carlisle, R, et al.
Foilsithe / Cruthaithe: (2006)

Targeting adenovirus gene delivery to activated tumour-associated vasculature via endothelial selectins.
de réir: Bachtarzi, H, et al.
Foilsithe / Cruthaithe: (2011)

Engineered CHO cell line with coxsackie and adenovirus gene enhance the susceptibility of adenovirus infection [electronic resource] /
de réir: Sayang Baba, 1987-
Foilsithe / Cruthaithe: (2013)

Electroporation optimisation of full-length of coxsackie and adenovirus receptor (CAR) tagged with EGFP into CHO cells [electronic resource] /
de réir: Hamidreza Aboulkheyr Estarabadi, 1980- author, et al.
Foilsithe / Cruthaithe: (2013)

Marine Lectins DlFBL and HddSBL Fused with Soluble Coxsackie-Adenovirus Receptor Facilitate Adenovirus Infection in Cancer Cells BUT Have Different Effects on Cell Survival
de réir: Bingbing Wu, et al.
Foilsithe / Cruthaithe: (2017-03-01)

Retargeting adenovirus gene therapy via the epidermal growth factor receptor
de réir: Morrison, J, et al.
Foilsithe / Cruthaithe: (2006)

Tropism ablation and stealthing of oncolytic adenovirus enhances systemic delivery to tumors and improves virotherapy of cancer.
de réir: Green, N, et al.
Foilsithe / Cruthaithe: (2012)

Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies
de réir: Fisher, K, et al.
Foilsithe / Cruthaithe: (2001)

Cetuximab retargeting of adenovirus via the epidermal growth factor receptor for treatment of intraperitoneal ovarian cancer.
de réir: Morrison, J, et al.
Foilsithe / Cruthaithe: (2009)

Ultrasound-enhanced delivery of polymer-coated oncolytic adenovirus for tumour growth inhibition
de réir: Carlisle, R, et al.
Foilsithe / Cruthaithe: (2011)

Variation in the affinity of three representative avian adenoviruses for the cellular coxsackievirus and adenovirus receptor
de réir: Yapeng Song, et al.
Foilsithe / Cruthaithe: (2024-02-01)

Adenovirus: teaching an old dog new tricks.
de réir: Seymour, L, et al.
Foilsithe / Cruthaithe: (2011)

Histone Deacetylase Inhibitors Restore Cell Surface Expression of the Coxsackie Adenovirus Receptor and Enhance CMV Promoter Activity in Castration-Resistant Prostate Cancer Cells
de réir: Laura Kasman, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Degradation and inactivation of adenovirus in water by photo-electro-oxidation
de réir: G. S. Monteiro, et al.

Comparison of molecular strategies for breast cancer virotherapy using oncolytic adenovirus.
de réir: Bazan-Peregrino, M, et al.
Foilsithe / Cruthaithe: (2008)

Complement receptor 1 is a sialic acid-independent erythrocyte receptor of Plasmodium falciparum.
de réir: Carmenza Spadafora, et al.
Foilsithe / Cruthaithe: (2010-06-01)

The effect of polymer coating and different adenovirus serotypes on the innate immune responses to intraperitoneal adenovirus
de réir: Thoma, C, et al.
Foilsithe / Cruthaithe: (2008)

Identification of novel human adenovirus candidates using the coxsackievirus and adenovirus receptor for cell entry
de réir: Kemal Mese, et al.
Foilsithe / Cruthaithe: (2020-04-01)